Health Condition 1: R70-R79- Abnormal findings on examination of blood, without diagnosis Health Condition 2: K00-K95- Diseases of the digestive system Health Condition 3: M00-M99- Diseases of the musculoskeletal system and connective tissue
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patient with any of micronutrient deficiency- Vit D, Iron, Calcium, Vit B-12, Magnesium,Zinc, Folic Acid- Requiring any External panchakarma therapy, Independent of Sex, eating habits or socio- economic status
Exclusion criteria
Exclusion criteria: Patients who are contraindicated for niruha basti and anuvasan basti like skin disorders, ascites, intestinal perforation ,intestinal obstruction etc. will not be included in the trial (Group A) Patients with comorbid condition such as hypertension(systolic >150mmhg and diastolic >100 mmhg despite anti hypertensive medication) and diabetes mellitus (having HBA1c >7%) despite anti diabetic medication) Pregnant women and lactating mothers Patient suffering from major illness such as malignancy, HIV and TB Patient requiring emergency treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of the effect of basti on objective parameters of Vitamin D, Vitamin B12, Serum iron, Serum zinc, Serum calcium, Serum magnesium, and Serum folic acid. Timepoint: Vitamin D, Vitamin B12, Serum iron, Serum zinc, Serum calcium, Serum magnesium, and Serum folic acid. [Time frame:45th day] | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Assessment of quality of life using the questionnaire of WHO - QOL BREF Scale. 2.Assessment of absorption of Balaguduchyadi basti in the systemic circulation.Timepoint: 1.Questionnaire of WHO-QOL Bref Scale.[Time frame:45th day] 2.HPLC [Time frame: between 1st to 2nd day] | — |
Countries
India
Contacts
Ayurvedic and Unani Tibbia College and Hospital